儿童中的Levothyroxine中毒:来自土耳其的多中心研究
Kübra Şen Küçük1, Şule Demir2, Reyhan Deveci Sevim1
1Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Aydın Adnan Menderes University, Aydın, Turkiye.
Turkish journal of medical sciences
|March 12, 2026
概括
儿童中毒通常无症状,在三分之一的病例中出现轻度症状,如心动减速. 患有levothyroxine过量服用的儿童的整体预后是有利的.
科学领域:
- 儿科急救医学 儿科急救医学
- 临床毒理学 临床毒理学
- 内分泌学 在内分泌学.
背景情况:
- 在儿童中,levothyroxine中毒带来了独特的管理挑战.
- 了解临床特征和治疗对于儿科护理至关重要.
研究的目的:
- 为了调查临床特征,实验室发现,以及治疗策略的儿科莱沃西中毒.
- 为了分析儿童的随访结果与levothyroxine过量.
主要方法:
- 儿科患者 (≤18岁) 经过急性摄入levothyroxine (2010-2023) 的多中心回顾性研究.
- 数据提取包括临床表现,实验室结果和治疗方式.
- 甲状腺功能测试 (TFT) 使用特定年龄的范围来解释.
主要成果:
- 分析了45名儿科患者;80%的摄入是意外的,20%是故意的.
- 症状发生在33.3%的人中,主要是高心率;较高的Levothyroxine剂量与症状相关.
- 在51.1%的患者中观察到异常的TFT;在51.1%的患者中使用活性炭;在26.7%的患者中使用胃洗.
结论:
- 儿童中毒通常无症状或呈现轻度至中度症状.
- 儿童摄入levothyroxine的预后通常是有利的.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
417
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion
414
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmaceutical Poisoning: Potential Scenarios
118
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
118
Pharmaceutical Poisoning: Treatment Strategies
286
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
286
Hyperthyroidism I: Introduction
64
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
64
Hyperthyroidism II: Pathophysiology
58
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
58
